Atlas Trials

Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor Malignancies

Clinical trial NCT03209401 · TERMINATED

Trial details

NCT number
NCT03209401
Sponsor
Georgetown University
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor, AdultHomologous Recombination Deficiency
Start date
2017-10-13
Primary completion
2023-10-16
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.